Synovus Financial’s Exelixis EXEL Stock Holding History

Synovus Financial’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-961	Closed	-$17K	–	1724
2020 Q1	$17K	Buy	+961	New	+$17.6K	﹤0.01%	1417

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Synovus Financial's EXEL Position: Q2 2020 in Review

Synovus Financial sold out of Exelixis (EXEL) in Q2 2020, closing a stake of 961 shares — an estimated $17K sold.

Synovus Financial first reported a position in EXEL in Q1 2020 and held it in 1 quarter. The position peaked at $17K in Q1 2020. 374 funds tracked by Wall St. Rank hold EXEL as of Q2 2020.

Synovus Financial reported no remaining Exelixis position as of Q2 2020 after selling out during the quarter.
Synovus Financial sold 961 Exelixis shares in Q2 2020, an estimated $17K.
Synovus Financial first reported a position in Exelixis in Q1 2020 and held it in 1 quarter.
Synovus Financial's Exelixis position peaked at $17K in Q1 2020.
374 funds tracked by Wall St. Rank held Exelixis as of Q2 2020.

Based on Synovus Financial's 13F filing for Q2 2020, filed 10 Aug 2020.